Royal Society of Chemistry, Chemical Science, 40(14), p. 11033-11039, 2023
DOI: 10.1039/d3sc03785a
Full text: Download
A Ru-based artificial metalloenzyme (ArM) at just 1–5 mol% could catalyze olefin metathesis in blood to construct various molecular scaffolds. The cancer-targeting ArM at a low dosage could elicit tumor growth inhibition by in vivo drug synthesis.